Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are actively engaged in developing next generation vaccines for Covid-19.
The Global mRNA Vaccine and Therapeutic Market is estimated at USD 29672.31 Million in the year 2025. The growing occurrences of chronic and infectious diseases, such as diabetes, HIV, cancer and CVDs, is one of the major key factors driving the growth of the market. The growing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections as well as inability of traditional vaccine approach to find vaccines at the critical time are also providing a boost to the market growth. Compared to conventional medicines, mRNA vaccines and Therapeutics are developed with the help of advanced technologies which are more effective against pathogens, have higher effectiveness, improved immunogenicity and require less cost to produce. Moreover, developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market growth.
Covid-19 vaccines are expected to hold largest share of mRNA Vaccine and Therapeutics market. The standardisation of cancer treatment segment, during the forecast period 2026-2030 is expected to be the largest contributor to the market growth. The major reason is the increase in the number of cancer patient around the world and it becomes imperative to have a set of standards for its treatment.
North America holds the largest share of the mRNA vaccines and therapeutics market for non-Covid-19 vaccines due to the growing need to develop transformative therapeutics, increasing fund infusions, a favorable regulatory environment, and massively growing attention to establish precision medicine, among others. Rising prevalence of cancer and other diseases among the developing economies of Asia region is augmenting the demand of mRNA Vaccine and Therapeutics in APAC region.
Scope of the Report • The report analyses the mRNA Vaccine and Therapeutic Market by value (USD Million).
• The report analyses the mRNA Vaccine and Therapeutic Market by Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases and Others).
• The report analyses the mRNA Vaccine and Therapeutic Market by End User (Hospitals & Clinics, Research Organization and Others).
• The Global mRNA Vaccine and Therapeutic Market has been analysed By Region (North America Europe, Asia Pacific, LAMEA) By Country (United States, Canada, Germany, U.K, France, Switzerland, Russia, China, Japan, and India).
• The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by product, By End User.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include AstraZeneca Plc, Bayer Group, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Moderna, BioNtech, Sangamo Therapeutics, Crispr Therapeutics, Intellia Therapeutics.
• The report presents the analysis of mRNA Vaccine and Therapeutic market for the forecast period of 2021-2030.
Key Target Audience
• Biotechnology Companies
• Pharmaceutical and Healthcare Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities
Our reports have been used by over 10K customers, including:
The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Additionally,...
The Global Digital Therapeutics Market size is expected to reach $14.5 billion by 2027, rising at a market growth of 21.8% CAGR during the forecast period. Digital therapeutics is a group of applications, which assist in curing diseases by altering patient’s behaviour and offering remote supervision to enhance long-term health results. There...
The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4billion in 2021, at a CAGR of 31.4%. Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in...
The global neoantigens market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18.49% during 2020-2028. Cancer has emerged as a leading cause of death worldwide.According to the World Health Organization (WHO), cancer was the first leading cause of death...
The non-invasive aesthetic treatment market was valued at US$ 6,504.19 million in 2020 and is projected to reach US$ 18,656.54 million by 2028; it is expected to grow at a CAGR of 14.08% during 2020-2028. The market growth is attributed to the rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness...
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The Asia Pacific Digital Therapeutics Market would witness market growth of 23.2% CAGR during the forecast period (2021-2027). Digital therapeutics refers to healthcare solution and treatment option, which uses digital technologies to cure patients with any kind of medical or psychological problem. It offers a whole new approach for...
272 pages •
By The Business Research Company
• Mar 2021
Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market. Description: Where is the largest and fastest growing...
The Latin America, Middle East and Africa Digital Therapeutics Market would witness market growth of 22.8% CAGR during the forecast period (2021-2027). There is an increasing demand for digital therapeutics across the globe, due to the rising adoption of smartphones & tablets along with healthcare apps, increasing cases of chronic diseases,...
United Arab Emirates
Chronic Disease Prevalence
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.